FindTrial
Sign In

Diagnostic clinical study of a novel detection of lung cancer in human exhalation

Diagnostic clinical study of quantum cascade lasers (QCL) detection of lung cancer in human exhalation

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039838
Enrollment
Unknown
Registered
2020-11-12
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Gold Standard:Pathological diagnosis of lung cancer
Index test:quantum&#32
cascade&#32
lasers(QCL)&#32
detection&#32
of&#32
lung&#32
cancer&#32
in&#32
human&#32
exhalation,testing&#32
its&#32
sensitivity&#32
and&#32
specificity

Sponsors

Sichuan Cancer Hospital and Institute
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Subjects: First diagnosed in Sichuan Provincial Cancer Hospital due to lung occupation;Physical examination subjects: healthy subjects who underwent low-dose CT physical examination screening;Age 18-70 years old, regardless of gender, sign informed consent.

Exclusion criteria

Exclusion criteria: Having other malignant tumors;Severe bronchial asthma;Severe liver function impairment;Severe kidney disease and acute inflammation.

Design outcomes

Primary

MeasureTime frame
exhaled breath VOCs;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactLi Qiang

Sichuan Cancer Hospital and Institute

liqiang1907@vip.sina.com+86 18908178887

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026